Pictet Asset Management
ORKA

Pictet Asset Management’s Oruka Therapeutics ORKA Stock Holding History

Pictet Asset Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.9M Buy
+619,076
New +$41.2M 0.06% 307

Other funds holding ORKA

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Pictet Asset Management's ORKA Position: Q2 2026 in Review

Pictet Asset Management opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 619,076 shares worth $58.9M. The stake represents 0.06% of the portfolio and ranks #307 among its holdings.

49 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Pictet Asset Management held 619,076 shares of Oruka Therapeutics worth $58.9M as of Q2 2026.
  • Oruka Therapeutics was a new Pictet Asset Management position in Q2 2026.
  • Oruka Therapeutics made up 0.06% of Pictet Asset Management's portfolio in Q2 2026, its #307 holding.
  • 49 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.